|
ARPC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.218300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.238120E-02 |
| Normal-vs-Stage2 |
1.710010E-01 |
| Normal-vs-Stage3 |
2.547900E-02 |
| Normal-vs-Stage4 |
4.924100E-02 |
| Stage1-vs-Stage2 |
1.98198999999954E-05 |
| Stage1-vs-Stage3 |
5.812200E-01 |
| Stage1-vs-Stage4 |
7.104600E-01 |
| Stage2-vs-Stage3 |
9.69269999999689E-05 |
| Stage2-vs-Stage4 |
8.564200E-04 |
| Stage3-vs-Stage4 |
9.313000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.881100E-03 |
| Normal-vs-AfricanAmerican |
1.706770E-01 |
| Normal-vs-Asian |
2.876400E-02 |
| Caucasian-vs-AfricanAmerican |
3.834400E-01 |
| Caucasian-vs-Asian |
9.648000E-01 |
| AfricanAmerican-vs-Asian |
4.698800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.199040E-01 |
| Normal-vs-Female |
2.530300E-02 |
| Male-vs-Female |
5.377000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.716900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.414370E-01 |
| Normal-vs-Age(61-80Yrs) |
2.670000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.735800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.373700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.269200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.983400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.199000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.341600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.533000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.718200E-02 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
4.007600E-02 |
| Classical-VS-Normal |
3.422400E-04 |
| Tall-VS-Follicular |
1.68310000003835E-06 |
| Tall-VS-Other |
3.743800E-02 |
| Tall-VS-Normal |
4.015400E-04 |
| Follicular-VS-Other |
4.960200E-01 |
| Follicular-VS-Normal |
1.727740E-02 |
| Other-VS-Normal |
6.803200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.652400E-01 |
| Normal-vs-N1 |
3.139000E-01 |
| N0-vs-N1 |
6.980200E-01 |
|
|
